|
|
Volumn 2, Issue 2, 2008, Pages 79-90
|
|
Comparison of the efficacy and safety of a combination tablet of niacin extended-release and simvastatin with simvastatin 80 mg monotherapy: the SEACOAST II (high-dose) study
a
|
|
Author keywords
Antilipemic agents; Cholesterol; Dyslipidemias; Hypertriglyceridemia
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTILIPEMIC AGENT;
APOLIPOPROTEIN A1;
APOLIPOPROTEIN B;
ATORVASTATIN;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
IBUPROFEN;
LIPOPROTEIN A;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
NICOTINIC ACID;
NICOTINIC ACID PLUS SIMVASTATIN;
NONSTEROID ANTIINFLAMMATORY AGENT;
PRAVASTATIN;
ROSUVASTATIN;
SIMCOR;
SIMVASTATIN;
TRIACYLGLYCEROL;
UNCLASSIFIED DRUG;
ABDOMINAL PAIN;
ADULT;
AGED;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ARTICLE;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
BACKACHE;
BEDTIME DOSAGE;
CLINICAL TRIAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED RELEASE FORMULATION;
CONTROLLED STUDY;
CREATINE KINASE BLOOD LEVEL;
DIABETES MELLITUS;
DIARRHEA;
DIZZINESS;
DOUBLE BLIND PROCEDURE;
DRUG DOSE COMPARISON;
DRUG DOSE INCREASE;
DRUG DOSE TITRATION;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG INDUCED HEADACHE;
DRUG MEGADOSE;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DYSLIPIDEMIA;
DYSPEPSIA;
FATIGUE;
FEMALE;
FLUSHING;
GASTRITIS;
GLUCOSE BLOOD LEVEL;
GOUT;
HIGH RISK PATIENT;
HUMAN;
HYPERGLYCEMIA;
LEUKOCYTE COUNT;
LOW DRUG DOSE;
LOW FAT DIET;
MAJOR CLINICAL STUDY;
MALE;
MONOTHERAPY;
MULTICENTER STUDY;
MUSCLE CRAMP;
MYALGIA;
MYOPATHY;
NAUSEA;
PATIENT COMPLIANCE;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PRURITUS;
RANDOMIZED CONTROLLED TRIAL;
RHABDOMYOLYSIS;
SIDE EFFECT;
TABLET;
URTICARIA;
|
|
EID: 40649097282
PISSN: 19332874
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jacl.2008.02.004 Document Type: Article |
|
Times cited : (36)
|
|
References (53)
|
